Promising results from a #malaria #vaccine candidate: http://t.co/Dk3vUAl9r4 Read the full @PLOSONE study here: http://t.co/8NMmbY5cbm
This is a paper about improved Malaria vaccine produced by the Japanese researchers. http://t.co/q4kt94O7hf
PLOSONE: Phase 1b Randomized Trial and Follow-Up Study in Uganda of the Blood-Stage Malaria Vaccine Candidate BK-SE36 http://t.co/idZq8R2zMg
PLOS ONE: Phase 1b Randomized Trial and Follow-Up Study in Uganda of the Blood-Stage Malaria... http://t.co/2pBO0dr9cB
Malaria vaccine: two-stage, randomized, single-blinded, placebo-controlled phase 1b trial. Safe and immunogenic. http://t.co/o5KKK7fXlT
Like 1884 all over again! RT @CharlesCMann 1st randomized clinical trial shows Japan malaria vaccine safe, effective: http://t.co/jULXXP3zKj
RT @CharlesCMann: A big deal, if it pans out: 1st randomized clinical trial shows Japan malaria vaccine safe, effective: http://t.co/2DjOEV1pj4
Malaria vaccine: two-stage, randomized, single-blinded, placebo-controlled phase 1b trial. Safe and immunogenic. http://t.co/o5KKK7fXlT
.@AlbertoAmmann Es un blog. No es "prueba" de nada. Una prueba tiene más bien este aspecto: http://t.co/SnzCc6poWF
.@AlbertoAmmann Es un blog. No es "prueba" de nada. Una prueba tiene más bien este aspecto: http://t.co/SnzCc6poWF
A big deal, if it pans out: 1st randomized clinical trial shows Japan malaria vaccine safe, effective: http://t.co/2DjOEV1pj4
This malaria vaccine trial is small (n=96), not designed for efficacy and barely significant (p=0.04) but exciting http://t.co/3gZEuzhUOX
This malaria vaccine trial is small (n=96), not designed for efficacy and barely significant (p=0.04) but exciting http://t.co/3gZEuzhUOX
阪大の研究所が熱帯熱マラリアの新ワクチン開発に成功-IBTimes:http://t.co/rjseZdCC3c 文献 http://t.co/aKOgAonS5I 感染例は29/66に対し7/33(1ml接種)、リスク比0.48(95%CI,0.24–0.98;p=0.04)。
たぶんてつるコロンか蝉ぐらふの人が書いてくれるんじゃないかな:PLOS ONE: Phase 1b Randomized Trial and Follow-Up Study in Uganda of the Blood-Sta... http://t.co/9cZQAN1TZz
Phase 1b Randomized Trial and Follow-Up Study in Uganda of the Blood-Stage Malaria Vaccine Candidate BK-SE36. http://t.co/4FfZSlN9W8
Phase 1b Randomized Trial and Follow-Up Study in Uganda of the Blood-Stage Malaria Vaccine Candidate BK-SE36. http://t.co/R05szb1MTt
Phase 1b Randomized Trial and Follow-Up Study in Uganda of the Blood-Stage Malaria Vaccine Candidate BK-SE36. http://t.co/lN4L9Fziv0